Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · GE HealthCare (GEHC)

GE HealthCare renews $0.5 billion 364-day revolving credit facility, maturing February 2027

Neutral Impact 2 of 5 financing Written later

GE HealthCare entered into a new 364-day, $0.5 billion senior unsecured revolving credit agreement with JPMorgan Chase Bank, N.A. as administrative agent, replacing an identical-sized facility dated March 27, 2025, which was terminated without penalty on February 26, 2026. The filing describes a routine refinancing of a short-term credit line, and the filing does not state any amount drawn or any change in results.

Key points

  • New $0.5 billion 364-day revolving credit facility dated February 26, 2026, maturing February 25, 2027
  • Replaces the 2025 364-Day Revolving Credit Agreement of March 27, 2025, which was terminated without penalty on February 26, 2026
  • Pricing based on the Company's senior unsecured long-term debt ratings; includes customary covenants and change-of-control default

The filing

CompanyGE HealthCare (GEHC)
Form8-K, current report
Filed with the SECFeb 27, 2026, 4:15 PM ET
Accession number0001932393-26-000010

Items reported: 1.01 Material Definitive Agreement1.02 Termination of Material Agreement2.03 New Direct Financial Obligation

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:30 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 27, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.